Tobii prices its initial public offering at SEK 25 per share – trading commences on Nasdaq Stockholm today

Tobii AB

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, SWITZERLAND, SOUTH AFRICA, SINGAPORE, HONG KONG OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.

Stockholm April 24, 2015—Tobii AB (publ) (“Tobii” or the “Company”) announces the outcome of the initial public offering (the “Offering”) of the Company’s shares and the listing on Nasdaq Stockholm. The Offering, consisting of newly issued shares and sale of existing shares, attracted strong interest both among Swedish and international institutional investors as well as among the general public in Sweden. The Offering was over-subscribed multiple times.

The Offering in brief

  • The price per share of SEK 25 gives Tobii a market capitalization of SEK 2.1 billion before exercise of the over-allotment option.
  • The Offering consists of 16,000,000 newly issued shares that have been offered by the Company and 1,901,000 existing shares that have been offered by selling shareholders[1]. In total, the Offering thus comprises 17,901,000 shares, corresponding to 21% of the total number of shares outstanding in Tobii[2], before a possible exercise of the over-allotment option.
  • The Company will receive gross proceeds of approximately SEK 400 million through the issue of new shares as part of the Offering, before a possible exercise of the over-allotment option.
  • The Company has granted the Joint Bookrunners an over-allotment option, of up to 2,685,150 newly issued shares, which is exercisable in whole or part for a period of 30 day as of April 24, 2015. If the over-allotment option is exercised in full, it would result in additional gross proceeds of approximately SEK 67 million to the Company.
  • Invifed AB (a wholly-owned subsidiary to Investor AB), The Sixth AP-fund and RAM ONE have committed to subscribe for shares in the Offering. Their shareholdings will amount to 19.5%, 7.3% and 1.9%, respectively, of the total number of shares in the Company following the Offering, before a possible exercise of the over-allotment option. Invifed AB will after the completion of the Offering remain the largest shareholder of the Company.
  • The total number of outstanding shares in the Company comprises 84,927,883 after the Offering, before a possible exercise of the over-allotment option.
  • Settlement is expected to take place on or around April 28, 2015.
  • Trading of the Company’s shares on Nasdaq Stockholm commences today April 24, 2015 under the trading symbol “TOBII”.

Henrik Eskilsson, CEO and co-founder, comments:

“We are proud and pleased over the large interest in subscribing for shares in Tobii among the general public and institutional investors. We see the strong demand as a good mark on our established business units and as a sign of strong confidence in Tobii’s ability to take our world-leading eye-tracking technology to exciting new application areas. Now we look forward to accomplishing this as a listed company on Nasdaq Stockholm.”

Kent Sander, Chairman of the Board, comments:

“This is an important milestone for Tobii and we believe that a presence on the public market will create favorable conditions for Tobii to continue to evolve. Our strong market positions and potential for continued growth is reflected in the large investor interest in the company. We now have a solid and diversified base of reputable institutional investors in Sweden and internationally, as well as a wide base of private investors. The Board and I look forward to continue to work with Tobii as a listed company.”

For more information, please contact:
Sara Hyléen, Corporate Communications Director of Tobii, tel: +46 70 9161641, email: sara.hyleen@tobii.com 

About Tobii
Tobii is the global leader in eye tracking. Our vision is a world where all technology works in harmony with natural human behavior. Tobii has pioneered research in many fields and enables communication for tens of thousands of people with special needs. We also focus on changing how people interact with technology in computers, games and cars. Tobii operates through three business units: Tobii Dynavox makes specially designed computers that are controlled by eye movement or touch screens for use by people with special needs due to spinal cord injuries, CP, ALS or other medical conditions. Tobii Pro develops and sells eye-tracking equipment and services used today by more than 2,000 companies and 1,500 research institutions, including 49 of the world’s 50 highest ranked universities. Tobii Tech further develops Tobii’s technology for new volume markets such as computer games, personal computers and vehicles. Tobii covers the global market through its offices in Sweden (headquarters), the USA, China, Japan, Germany, the UK, and Norway, along with a global network of resellers. The Group has approximately 570 employees and has achieved rapid annual growth since it was founded in 2001. For more information, please visit www.tobii.com.

IMPORTANT INFORMATION

This announcement is not and does not form a part of any offer for sale of securities.

Copies of this announcement are not being made and may not be distributed or sent into the United States, Australia, Canada, Japan or any other jurisdiction in which such distribution would be unlawful or would require registration or other measures. The securities referred to in this announcement have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), and accordingly may not be offered or sold in the United States absent registration or an exemption from the registration requirements of the Securities Act and in accordance with applicable U.S. state securities laws. The Company does not intend to register any offering in the United States or to conduct a public offering of securities in the United States.

Any offering of the securities referred to in this announcement will be made by means of a prospectus. This announcement is not a prospectus for the purposes of Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the “Prospectus Directive”). Investors should not invest in any securities referred to in this announcement except on the basis of information contained in the aforementioned prospectus.

In any EEA Member State other than Sweden that has implemented the Prospectus Directive, this communication is only addressed to and is only directed at qualified investors in that Member State within the meaning of the Prospectus Directive, i.e., only to investors who can receive the offer without an approved prospectus in such EEA Member State.

This communication is only being distributed to and is only directed at persons in the United Kingdom that are (i) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the “Order”) or (ii) high net worth entities, and other persons to whom this announcement may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as “Relevant Persons”). This communication must not be acted on or relied on by persons who are not Relevant Persons. Any investment or investment activity to which this communication relates is available only to Relevant Persons and will be engaged in only with Relevant Persons. Persons distributing this communication must satisfy themselves that it is lawful to do so.

Matters discussed in this announcement may constitute forward-looking statements. Forward-looking statements are statements that are not historical facts and may be identified by words such as “believe,” “expect,” “anticipate,” “intends,” “estimate,” “will,” “may,” "continue," “should” and similar expressions. The forward-looking statements in this release are based upon various assumptions, many of which are based, in turn, upon further assumptions. Although Tobii believes that these assumptions were reasonable when made, these assumptions are inherently subject to significant known and unknown risks, uncertainties, contingencies and other important factors which are difficult or impossible to predict and are beyond its control. Such risks, uncertainties, contingencies and other important factors could cause actual events to differ materially from the expectations expressed or implied in this release by such forward-looking statements. The information, opinions and forward-looking statements contained in this announcement speak only as at its date, and are subject to change without notice.

 

Footnotes

[1] Among selling shareholders are John Elvesjö, Board Member and member of the Company’s management team, offering 150,000 shares, and Board member Nils Bernhard, offering 275,000 shares.

[2] Before dilution effects from existing employee stock options and warrants.